Seeing Is Believing
ALNY is currently covered by 26 analysts with an average price target of $187.24. This is a potential upside of $43.93 (30.65%) from yesterday's end of day stock price of $143.31.
Alnylam Pharmaceuticals's activity chart (see below) currently has 327 price targets and 334 ratings on display. The stock rating distribution of ALNY is 65.14% BUY and 34.86% HOLD.
Analysts average stock forecasts to be materialized ratio is 75.1% with an average time for these price targets to be met of 221.44 days.
Highest price target for ALNY is $395, Lowest price target is $161, average price target is $187.24.
Most recent stock forecast was given by KOSTAS BILIOURIS from BMO on 27-Mar-2024.
Currently out of the existing stock ratings of ALNY, 71 are a BUY (65.14%), 38 are a HOLD (34.86%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
234
$90.2 (62.73%)
234
1 months 2 days ago
0/3 (0%)
$79.61 (51.56%)
Buy
235
$91.2 (63.42%)
235
2 months 9 days ago
2/14 (14.29%)
$85.31 (56.99%)
149
Buy
227
$83.2 (57.86%)
237
2 months 13 days ago
14/22 (63.64%)
$80 (54.42%)
171
Hold
161
$17.2 (11.96%)
171
2 months 13 days ago
2/2 (100%)
$14 (9.52%)
5
Buy
225
$81.2 (56.47%)
250
2 months 13 days ago
2/6 (33.33%)
$78 (53.06%)
435
What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?